228.49
-4.72 (-2.02%)
| 前收盘价格 | 233.21 |
| 收盘价格 | 231.43 |
| 成交量 | 1,224,341 |
| 平均成交量 (3个月) | 1,419,793 |
| 市值 | 37,559,611,392 |
| 市盈率 (P/E TTM) | 44.54 |
| 预期市盈率 (P/E Forward) | 27.55 |
| 价格/销量 (P/S) | 12.94 |
| 股市价格/股市净资产 (P/B) | 5.55 |
| 52周波幅 | |
| 利润日期 | 4 Mar 2026 |
| 营业毛利率 | 27.34% |
| 营业利益率 (TTM) | 30.79% |
| 稀释每股收益 (EPS TTM) | 4.70 |
| 季度收入增长率 (YOY) | 16.70% |
| 季度盈利增长率 (YOY) | 41.20% |
| 总债务/股东权益 (D/E MRQ) | 1.24% |
| 流动比率 (MRQ) | 4.61 |
| 营业现金流 (OCF TTM) | 1.20 B |
| 杠杆自由现金流 (LFCF TTM) | 1.05 B |
| 资产报酬率 (ROA TTM) | 6.90% |
| 股东权益报酬率 (ROE TTM) | 14.06% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 看跌 | 看跌 |
| Health Information Services (全球的) | 看跌 | 看跌 | |
| 股票 | Veeva Systems Inc. | 看跌 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 3.0 |
| 内部交易活动 | -3.0 |
| 价格波动 | -1.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.20 |
|
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Mid Growth |
| 内部持股比例 | 8.55% |
| 机构持股比例 | 86.32% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Linonia Partnership Lp | 30 Sep 2025 | 2,970,254 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 355.00 (Needham, 55.37%) | 购买 |
| 中 | 319.00 (39.61%) | |
| 低 | 280.00 (UBS, 22.54%) | 保留 |
| 280.00 (Canaccord Genuity, 22.54%) | 保留 | |
| 平均值 | 314.56 (37.67%) | |
| 总计 | 6 购买, 3 保留 | |
| 平均价格@调整类型 | 247.97 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wells Fargo | 25 Nov 2025 | 333.00 (45.74%) | 购买 | 239.95 |
| Citigroup | 24 Nov 2025 | 319.00 (39.61%) | 购买 | 235.74 |
| BTIG | 21 Nov 2025 | 340.00 (48.80%) | 购买 | 244.06 |
| 17 Oct 2025 | 340.00 (48.80%) | 购买 | 283.73 | |
| Baird | 21 Nov 2025 | 319.00 (39.61%) | 购买 | 244.06 |
| Barclays | 21 Nov 2025 | 305.00 (33.49%) | 购买 | 244.06 |
| Canaccord Genuity | 21 Nov 2025 | 280.00 (22.54%) | 保留 | 244.06 |
| Needham | 21 Nov 2025 | 355.00 (55.37%) | 购买 | 244.06 |
| 17 Oct 2025 | 355.00 (55.37%) | 购买 | 283.73 | |
| UBS | 21 Nov 2025 | 280.00 (22.54%) | 保留 | 244.06 |
| BMO Capital | 13 Nov 2025 | 300.00 (31.30%) | 保留 | 291.70 |
| 显示更多 | ||||
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 08 Jan 2026 | 公告 | Veeva to Present at the J.P. Morgan 2026 Healthcare Conference |
| 08 Jan 2026 | 公告 | Veeva and BioMarin Form Long-Term Strategic Partnership |
| 08 Jan 2026 | 公告 | Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing |
| 07 Jan 2026 | 公告 | Novo Nordisk International Operations Commits to Veeva Vault CRM |
| 05 Jan 2026 | 公告 | Veeva Announces Share Repurchase Program |
| 04 Dec 2025 | 公告 | Veeva to Present at Upcoming Investor Conference |
| 03 Dec 2025 | 公告 | Veeva AI Agents Now Available to Increase Productivity and Customer Centricity |
| 24 Nov 2025 | 公告 | Veeva Announces Expanded Partnership with Roche |
| 20 Nov 2025 | 公告 | Veeva Announces Fiscal 2026 Third Quarter Results |
| 04 Nov 2025 | 公告 | Veeva Basics Adopted by More Than 100 Emerging Biotechs to Simplify and Standardize Operations |
| 30 Oct 2025 | 公告 | Veeva to Release Fiscal 2026 Third Quarter Results on November 20, 2025 |
| 显示更多 | ||
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合